Introduction Sodium-glucose co-transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as crucial pharmacological agents in managing…
1. What is Semaglutide? Semaglutide kidney protection, Semaglutide is a GLP-1 (Glucagon-Like Peptide-1) receptor agonist originally developed for type 2…